Vysis CLL FISH Probe Kit may fail to detect genetic deletion
Abbott is recalling Vysis CLL FISH Probe Kits that may not detect 13q deletions in patient samples. This could lead to missed diagnosis of a genetic abnormality used in cancer treatment planning.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a diagnostic device with potential for false-negative results that could lead to missed detection of an important genetic abnormality. Although no illnesses or injuries have been reported, the hazard represents a risk-of-harm product where diagnostic failure has not yet caused reported patient harm.
Plain-English summary
Abbott Molecular, Inc. is recalling the Vysis CLL FISH Probe Kit, a laboratory diagnostic tool used to detect genetic abnormalities in chronic lymphocytic leukemia (CLL) patients. The kit applies fluorescence in situ hybridization (FISH) technology to identify genetic markers that inform cancer treatment decisions.
The affected kits may fail to detect the 13q deletion, a genetic abnormality that is actually present in patient samples. This test failure could result in missed identification of this important prognostic marker used in cancer treatment planning.
Approximately 186 units have been distributed worldwide, including across the United States and internationally.
Healthcare providers and laboratories should stop using the affected kits and contact Abbott Molecular, Inc. for replacement units and further instructions.
The recalled product
- Product
- Vysis CLL FISH Probe Kit with the following components: Vysis LSI p53 SpectrumOrange/ATM, SpectrumGreen and LSI D13S319, SpectrumOrange/ 13q34, SpectrumAqua/CEP 12 SpectrumGreen Probes
- Manufacturer
- Abbott Molecular, Inc.
- Hazard
- diagnostic-failure
- false-negative
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- UDI: (01)00884999042780(10)XXXXX(17)211015(240)04N02-021
- US Distribution: Part Number 04N02-021
- Lot Numbers 517086
- 518656
- International Distribution: List/Part Numbers (Lot Number): 04N02-021 (517086
- 518656)
- 04N02-022 (517516
- 519303)
- 05J83-001/Part 32-191025 (517068).
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- HighCRE Wireguided 18-20mm 240cm medical devices recalled for sterile breach
FDA (Devices) · 2026-07-08
- ModerateMedline Convenience Kits recalled for defective Lidocaine Ampules
FDA (Devices) · 2026-07-08
- ModerateProvena Midline Catheters recalled due to deficient manufacturing practices
FDA (Devices) · 2026-07-08
- ModeratePowerMidline Catheters Recalled for Deficient Manufacturing Practices
FDA (Devices) · 2026-07-08
- HighBoston Scientific CRE Pro Wireguided catheters recalled for packaging
FDA (Devices) · 2026-07-08